XERS

SEC source: 0001867096-24-000108 · wk-form4_1717618752.xml · nonDerivative · entry 1

SHERMAN JEFFREY W · CIK 0001230482 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,380

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 5, 2025 or the date of the Company's next annual meeting of stockholders.

SEC source: 0001867096-24-000067 · wk-form4_1715371447.xml · nonDerivative · entry 1

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By: The Schmid Family Trust dated August 15, 2017

Disclosed balance after: 16,400

F1 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001867096-24-000036 · wk-form4_1710797522.xml · derivative · entry 2

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 215,600 shares

Expires 2029-11-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The options to purchase shares of Xeris Biopharma Holdings Inc. common stock fully vested on October 5, 2021.

SEC source: 0001867096-24-000036 · wk-form4_1710797522.xml · nonDerivative · entry 1

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 751,412

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001867096-24-000041 · wk-form4_1712007900.xml · nonDerivative · entry 1

Kong Garheng · CIK 0001435183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,144

F1 · kind: Keveyis Sales 2023 Milestone achieved resulting in the settlement of the related Contingent Value Right ("CVR") in shares of Xeris Biopharma Holdings, Inc. (the "Company")'s Common Stock.

F2 · shares: The reporting person's right to receive additional shares pursuant to this earn-out right became fixed and irrevocable on October 5, 2021, the effective time of the Merger (as defined below), pursuant to the transaction agreement dated as of May 24, 2021 by and among Xeris Pharmaceuticals, Inc. ("Xeris"), Strongbridge Biopharma plc ("Strongbridge"), the Issuer ("HoldCo") and Wells MergerSub, Inc., a wholly owned subsidiary of HoldCo ("MergerSub"), where HoldCo acquired the entire issued and to be issued ordinary share capital of Strongbridge, and MergerSub merged with and into Xeris, with Xeris continuing as the surviving corporation and wholly owned subsidiary of HoldCo (the "Merger").

F3 · price: The number of shares of Common Stock for the CVR is equal to the product (A) $0.25 divided by the volume weighted average price for the Company's Common Stock as reported by Nasdaq for the ten (10) Trading Days immediately prior to October 5, 2021 and (B) the number of CVRs held by the holder as reflected on the CVR Register.

SEC source: 0001867096-24-000039 · wk-form4_1712007768.xml · nonDerivative · entry 1

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 840,983

F1 · kind: Keveyis Sales 2023 Milestone achieved resulting in the settlement of the related Contingent Value Right ("CVR") in shares of Xeris Biopharma Holdings, Inc. (the "Company")'s Common Stock.

F2 · shares: The reporting person's right to receive additional shares pursuant to this earn-out right became fixed and irrevocable on October 5, 2021, the effective time of the Merger (as defined below), pursuant to the transaction agreement dated as of May 24, 2021 by and among Xeris Pharmaceuticals, Inc. ("Xeris"), Strongbridge Biopharma plc ("Strongbridge"), the Issuer ("HoldCo") and Wells MergerSub, Inc., a wholly owned subsidiary of HoldCo ("MergerSub"), where HoldCo acquired the entire issued and to be issued ordinary share capital of Strongbridge, and MergerSub merged with and into Xeris, with Xeris continuing as the surviving corporation and wholly owned subsidiary of HoldCo (the "Merger").

F3 · price: The number of shares of Common Stock for the CVR is equal to the product (A) $0.25 divided by the volume weighted average price for the Company's Common Stock as reported by Nasdaq for the ten (10) Trading Days immediately prior to October 5, 2021 and (B) the number of CVRs held by the holder as reflected on the CVR Register.

SEC source: 0001867096-24-000043 · wk-form4_1712865937.xml · nonDerivative · entry 1

SHERMAN JEFFREY W · CIK 0001230482 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,380

F1 · kind: Keveyis Sales 2023 Milestone achieved resulting in the settlement of the related Contingent Value Right ("CVR") in shares of Xeris Biopharma Holdings, Inc. (the "Company")'s Common Stock.

F2 · shares: The reporting person's right to receive additional shares pursuant to this earn-out right became fixed and irrevocable on October 5, 2021, the effective time of the Merger (as defined below), pursuant to the transaction agreement dated as of May 24, 2021 by and among Xeris Pharmaceuticals, Inc. ("Xeris"), Strongbridge Biopharma plc ("Strongbridge"), the Issuer ("HoldCo") and Wells MergerSub, Inc., a wholly owned subsidiary of HoldCo ("MergerSub"), where HoldCo acquired the entire issued and to be issued ordinary share capital of Strongbridge, and MergerSub merged with and into Xeris, with Xeris continuing as the surviving corporation and wholly owned subsidiary of HoldCo (the "Merger").

F3 · price: The number of shares of Common Stock for the CVR is equal to the product (A) $0.25 divided by the volume weighted average price for the Company's Common Stock as reported by Nasdaq for the ten (10) Trading Days immediately prior to October 5, 2021 and (B) the number of CVRs held by the holder as reflected on the CVR Register.

SEC source: 0001867096-24-000034 · wk-form4_1710464612.xml · nonDerivative · entry 2

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By: The Schmid Family Trust dated August 15, 2017

Disclosed balance after: 11,000

F1 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001867096-24-000018 · wk-form4_1706738714.xml · nonDerivative · entry 1

Pieper Steven · CIK 0001875714 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,626,912

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.

SEC source: 0001867096-24-000014 · wk-form4_1706738662.xml · derivative · entry 3

Edick Paul R · CIK 0001531178 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2026-03-03

F3 · derivative.exercise_date: The award will vest in full on the two-year anniversary of the grant date.

F4 · derivative.underlying: Upon exercise, the Stock Appreciation Right will be settled in cash.

SEC source: 0001867096-24-000014 · wk-form4_1706738662.xml · nonDerivative · entry 1

Edick Paul R · CIK 0001531178 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,788,064

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.

SEC source: 0001867096-24-000017 · wk-form4_1706738697.xml · nonDerivative · entry 1

Shannon John Patrick Jr · CIK 0001553595 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,158,575

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.

SEC source: 0001867096-24-000015 · wk-form4_1706738674.xml · nonDerivative · entry 1

Hecht Beth · CIK 0001652410 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,554,968

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.

F2 · balance_after: These shares include 7,210 shares that were purchased on June 30, 2023 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.

SEC source: 0001867096-24-000016 · wk-form4_1706738685.xml · nonDerivative · entry 1

JOHNSON KENNETH ERLAND · CIK 0001743774 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 446,860

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.

F2 · balance_after: These shares include 2,077 shares that were purchased on June 30, 2023 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.

SEC source: 0001867096-24-000145 · wk-form4_1722633763.xml · nonDerivative · entry 9

Shannon John Patrick Jr · CIK 0001553595 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,148,061

F3 · date: This transaction is being reported late due to administrative oversight.

F11 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2024.

SEC source: 0001867096-24-000168 · wk-form4_1723234008.xml · nonDerivative · entry 10

Pieper Steven · CIK 0001875714 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,437,104

F1 · date: This transaction is being reported late due to administrative oversight.

F11 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2024.

SEC source: 0001867096-24-000170 · wk-form4_1723234030.xml · nonDerivative · entry 8

Hecht Beth · CIK 0001652410 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,380,802

F1 · date: This transaction is being reported late due to administrative oversight.

F10 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2024.

SEC source: 0001867096-24-000169 · wk-form4_1723234020.xml · nonDerivative · entry 8

JOHNSON KENNETH ERLAND · CIK 0001743774 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 373,036

F1 · date: This transaction is being reported late due to administrative oversight.

F10 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2024.

SEC source: 0001867096-24-000145 · wk-form4_1722633763.xml · nonDerivative · entry 8

Shannon John Patrick Jr · CIK 0001553595 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,258,811

F3 · date: This transaction is being reported late due to administrative oversight.

F10 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2024.

SEC source: 0001867096-24-000168 · wk-form4_1723234008.xml · nonDerivative · entry 9

Pieper Steven · CIK 0001875714 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,547,854

F1 · date: This transaction is being reported late due to administrative oversight.

F10 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2024.

SEC source: 0001867096-24-000170 · wk-form4_1723234030.xml · nonDerivative · entry 7

Hecht Beth · CIK 0001652410 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,426,711

F1 · date: This transaction is being reported late due to administrative oversight.

F9 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2024.

SEC source: 0001867096-24-000169 · wk-form4_1723234020.xml · nonDerivative · entry 7

JOHNSON KENNETH ERLAND · CIK 0001743774 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 388,167

F1 · date: This transaction is being reported late due to administrative oversight.

F9 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2024.

SEC source: 0001867096-24-000145 · wk-form4_1722633763.xml · nonDerivative · entry 7

Shannon John Patrick Jr · CIK 0001553595 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,280,961

F3 · date: This transaction is being reported late due to administrative oversight.

F9 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2024.

SEC source: 0001867096-24-000168 · wk-form4_1723234008.xml · nonDerivative · entry 8

Pieper Steven · CIK 0001875714 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,552,233

F1 · date: This transaction is being reported late due to administrative oversight.

F9 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2024.

SEC source: 0001867096-24-000170 · wk-form4_1723234030.xml · nonDerivative · entry 6

Hecht Beth · CIK 0001652410 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,446,386

F1 · date: This transaction is being reported late due to administrative oversight.

F8 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2024.

SEC source: 0001867096-24-000169 · wk-form4_1723234020.xml · nonDerivative · entry 6

JOHNSON KENNETH ERLAND · CIK 0001743774 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 398,914

F1 · date: This transaction is being reported late due to administrative oversight.

F8 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2024.

SEC source: 0001867096-23-000154 · wk-form4_1701292127.xml · nonDerivative · entry 2

SHERMAN JEFFREY W · CIK 0001230482 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By: JEFFREY W SHERMAN LIVING TRUST U/A DTD 03/21/2001

Disclosed balance after: 5,400

F1 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001867096-23-000149 · wk-form4_1700601408.xml · nonDerivative · entry 1

Pieper Steven · CIK 0001875714 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,176,912

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.92 to $1.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

SEC source: 0001867096-23-000151 · wk-form4_1700601584.xml · nonDerivative · entry 2

HALKUFF DAWN · CIK 0001743658 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By; DAWN HALKUFF REVOCABLE TRUST U/A DTD 08/25/2017

Disclosed balance after: 5,410

F1 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001867096-23-000145 · wk-form4_1700261903.xml · nonDerivative · entry 1

Shannon John Patrick Jr · CIK 0001553595 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,408,575

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6250 to $1.6400, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

SEC source: 0001867096-23-000147 · wk-form4_1700264146.xml · nonDerivative · entry 2

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By: The Schmid Family Trust dated August 15, 2017

Disclosed balance after: 6,500

F1 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001867096-23-000143 · wk-form4_1700082785.xml · nonDerivative · entry 2

PERSKY MARLA · CIK 0001270354 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By: Marla Susan Persky Revocable Trust u/a dated 9/23/2000

Disclosed balance after: 6,370

F1 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001867096-23-000117 · wk-form4_1691621818.xml · nonDerivative · entry 1

Edick Paul R · CIK 0001531178 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,288,064

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.365 to $2.3899, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

SEC source: 0001867096-24-000168 · wk-form4_1723234008.xml · nonDerivative · entry 7

Pieper Steven · CIK 0001875714 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,575,300

F1 · date: This transaction is being reported late due to administrative oversight.

F8 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of July 28, 2023.

SEC source: 0001867096-23-000097 · wk-form4_1686171475.xml · nonDerivative · entry 1

HALKUFF DAWN · CIK 0001743658 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,500

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 7, 2024 or the date of the Company's next annual meeting of stockholders.

SEC source: 0001867096-23-000103 · wk-form4_1686171739.xml · nonDerivative · entry 1

BORMANN-KENNEDY BARBARA-JEAN ANNE · CIK 0001635065 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,500

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 7, 2024 or the date of the Company's next annual meeting of stockholders.

SEC source: 0001867096-23-000093 · wk-form4_1686171315.xml · nonDerivative · entry 1

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,159

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 7, 2024 or the date of the Company's next annual meeting of stockholders.

SEC source: 0001867096-23-000101 · wk-form4_1686171645.xml · nonDerivative · entry 1

Kong Garheng · CIK 0001435183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,670

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 7, 2024 or the date of the Company's next annual meeting of stockholders.

SEC source: 0001867096-23-000099 · wk-form4_1686171564.xml · nonDerivative · entry 1

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 535,812

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 7, 2024 or the date of the Company's next annual meeting of stockholders.

SEC source: 0001867096-23-000095 · wk-form4_1686171393.xml · nonDerivative · entry 1

PERSKY MARLA · CIK 0001270354 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,500

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 7, 2024 or the date of the Company's next annual meeting of stockholders.

SEC source: 0001867096-23-000091 · wk-form4_1686171118.xml · nonDerivative · entry 1

SHERMAN JEFFREY W · CIK 0001230482 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,878

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 7, 2024 or the date of the Company's next annual meeting of stockholders.

SEC source: 0001867096-23-000050 · wf-form4_168012321668743.xml · nonDerivative · entry 1

Fairley Ricki Louise · CIK 0001971350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,000

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.

SEC source: 0001867096-23-000022 · wf-form4_167528596828835.xml · nonDerivative · entry 1

Pieper Steven · CIK 0001875714 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,148,912

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.

F2 · balance_after: These shares include 7,544 shares that were purchased on June 30, 2022 and 2,534 shares that were purchased on December 31, 2022 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.

SEC source: 0001867096-23-000023 · wf-form4_167528599539937.xml · nonDerivative · entry 1

Edick Paul R · CIK 0001531178 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,278,064

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.

SEC source: 0001867096-23-000024 · wf-form4_167528602235679.xml · nonDerivative · entry 1

Shannon John Patrick Jr · CIK 0001553595 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,377,806

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.

F2 · balance_after: These shares include 8,896 shares that were purchased on June 30, 2022 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.

SEC source: 0001867096-23-000020 · wf-form4_167528592477189.xml · nonDerivative · entry 1

Hecht Beth · CIK 0001652410 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 797,758

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.

F2 · balance_after: These shares include 5,039 shares that were purchased on June 30, 2022 and 5,898 shares that were purchased on December 31, 2022 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.

SEC source: 0001867096-23-000019 · wf-form4_167528590383194.xml · nonDerivative · entry 1

JOHNSON KENNETH ERLAND · CIK 0001743774 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,783

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.

F2 · balance_after: These shares include 1,460 shares that were purchased on June 30, 2022 and 1,700 shares that were purchased on December 31, 2022 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.

SEC source: 0001867096-23-000021 · wf-form4_167528594232700.xml · nonDerivative · entry 1

PRESTRELSKI STEVEN · CIK 0001744027 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 719,780

F1 · shares: These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.

SEC source: 0001867096-24-000145 · wk-form4_1722633763.xml · nonDerivative · entry 6

Shannon John Patrick Jr · CIK 0001553595 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,321,795

F3 · date: This transaction is being reported late due to administrative oversight.

F8 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2023.

SEC source: 0001867096-24-000168 · wk-form4_1723234008.xml · nonDerivative · entry 6

Pieper Steven · CIK 0001875714 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,585,500

F1 · date: This transaction is being reported late due to administrative oversight.

F7 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2023.